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Abstract
Total cholesterol, low-density lipoprotein cholesterol, triglyceride, and high-density lipoprotein cholesterol (HDL-C) levels
are among the most important risk factors for coronary artery disease. We tested for gene–gene interactions affecting the
level of these four lipids based on prior knowledge of established genome-wide association study (GWAS) hits, protein–
protein interactions, and pathway information. Using genotype data from 9,713 European Americans from the
Atherosclerosis Risk in Communities (ARIC) study, we identified an interaction between HMGCR and a locus near LIPC in
their effect on HDL-C levels (Bonferroni corrected Pc=0.002). Using an adaptive locus-based validation procedure, we
successfully validated this gene–gene interaction in the European American cohorts from the Framingham Heart Study
(Pc=0.002) and the Multi-Ethnic Study of Atherosclerosis (MESA; Pc=0.006). The interaction between these two loci is also
significant in the African American sample from ARIC (Pc=0.004) and in the Hispanic American sample from MESA
(Pc=0.04). Both HMGCR and LIPC are involved in the metabolism of lipids, and genome-wide association studies have
previously identified LIPC as associated with levels of HDL-C. However, the effect on HDL-C of the novel gene–gene
interaction reported here is twice as pronounced as that predicted by the sum of the marginal effects of the two loci. In
conclusion, based on a knowledge-driven analysis of epistasis, together with a new locus-based validation method, we
successfully identified and validated an interaction affecting a complex trait in multi-ethnic populations.
Citation: Ma L, Brautbar A, Boerwinkle E, Sing CF, Clark AG, et al. (2012) Knowledge-Driven Analysis Identifies a Gene–Gene Interaction Affecting High-Density
Lipoprotein Cholesterol Levels in Multi-Ethnic Populations. PLoS Genet 8(5): e1002714. doi:10.1371/journal.pgen.1002714
Editor: Scott M. Williams, Vanderbilt University, United States of America
Received January 11, 2012; Accepted March 30, 2012; Published May 24, 2012
Copyright:  2012 Ma et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was supported in part by NIH grants GM065509, HL072904, and U01-HG005715. AK is an Alfred P. Sloan Research Fellow. ARIC, FHS, and
MESA were supported by the National Heart, Lung, and Blood Institute. The funders had no role in study design, data collection and analysis, decision to publish,
or preparation of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ac347@cornell.edu (AGC); ak735@cornell.edu (AK)
. These authors were joint senior authors on this work.
Introduction
The catalog of genome-wide association studies (GWAS) [1] has
collected to date over 1,194 publications since the end of 2008, for
a total of over 5,697 single nucleotide polymorphisms (SNPs) that
are associated with complex human diseases and other complex
traits. However, most these associated SNPs exhibit a small effect
size, and collectively only explain a relatively small fraction of
additive variance [2,3,4,5]. Specifically, a recent meta-analysis of
several GWAS, studying a combined sample size between
,20,000 to ,100,000 individuals, identified 95 loci associated
with the level of one of total cholesterol (TC), low-density
lipoprotein cholesterol (LDL-C), triglyceride (TG), and high-
density lipoprotein cholesterol (HDL-C) [6]. In aggregate, these
loci explain only 25–30% of heritable variation for each trait [6].
Many hypotheses aiming to explain the missing heritability of
GWAS have been proposed, including structural variants, rare
variants, gene-environment interactions, epigenetics, and complex
inheritance [2,3,4,5]. Because gene-gene (epistatic) interactions
may contribute to missing heritability to some extent [7,8,9], here
we seek to find examples of pairs of loci that interact in their effects
on any of the four lipid levels, which are important risk factors of
coronary artery disease [10].
Epistasis has been investigated in order to understand the
relationship between genotype and phenotype since Bateson [11]
discovered in 1905 that some genes can suppress the effects of
others. Thereafter, a number of epistatic interactions have been
identified in QTL mapping studies or GWAS in humans [12,13]
and other organisms [14,15,16]. Studies of model organisms
suggest that gene-gene interactions are a common phenomenon
[17,18,19,20]. However, they have proven difficult to detect in
humans, chiefly due to the limited statistical power associated with
the large combinatorial number of tests and the skew towards low
minor allele frequencies [18,21]. Hence, in order to increase
power to detect gene-gene interactions in GWAS, a series of
methods have been developed to prioritize candidate SNPs using
prior knowledge of established GWAS hits [22], and recently also
using knowledge of protein-protein interactions (PPIs) [23,24] and
pathway information [25].
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have been reported in humans [12,26], replication of these
interactions in independent samples has proven difficult [13]. He
et al. [27] showed that this low replication is in part attributable to
low power and small effect sizes of tag SNPs in GWAS. For two
interacting causal loci, the observed interaction effect between two
respective tag SNPs (each tagging one of the causal loci) is
proportional to the underlying causal interaction effect multiplied
by the product of the two linkage disequilibrium (LD) coefficients
between each tag SNP and the respective causal variant. This
decrease in the measured interaction effect reduces the statistical
power of the interaction test and it also reduces the probability of
replication of significantly identified interactions. This reduction is
further exacerbated by heterogeneity in the LD structure between
different populations and among population samples. These are
the same problems that plague the power of single-marker GWAS
tests, but they are exacerbated in interaction testing, with a
quadratic dependence on LD between markers and causal loci,
which lead to a much greater reduction in power. Motivated by
this problem, Liu et al. [28] proposed a local validation analysis
and successfully replicated the loci of a few interactions underlying
common human diseases.
In this study, we aim to improve the power to detect gene-gene
interactions in existing large-scale GWAS data sets by consider-
ing for interaction testing only a highly focused set of candidate
SNPs extracted from prior information of known GWAS hits,
PPIs, and pathway information. To improve the power of
replicating gene-gene interaction signals in independent samples,
we introduce an adaptive locus-based validation procedure that
follows an approach similar to Liu et al. [28]. Applying these
procedures for testing for gene-gene interactions underlying lipid
levels, we discovered a significant interaction affecting HDL-C
levels, which provides new insights into the genetic architecture
of this complex trait. Using the adaptive locus-based validation
procedure, we also successfully replicated this novel interaction in
four independent cohorts, including two cohorts of different
ethnicity.
Results
Knowledge-driven identification of gene–gene
interactions
We tested the statistical significance of gene-gene interaction
between each pair of SNPs among 125 SNPs from 95 loci that
have been previously individually associated with any of the four
lipid levels [6] for a total of 7,750 tests, out of ,3 trillion possible
tests between each pair of SNPs in our data. Tests of interaction
were conducted using genotype data or imputed genotypes in a
sample of 9,713 European Americans (EAs) from the Atheroscle-
rosis Risk in Communities (ARIC) study [29] (Materials and
Methods). We used an F-test with four degrees of freedom within a
linear model framework for interaction testing [30,31]. This test
considers the 363 table of genotype pairs for two SNPs and tests
for significant interaction between the two SNPs on top of any
additive or dominance effects that each of the SNPs might exhibit
by itself. For consideration of statistical power and robustness, we
discarded from testing pairs of SNPs for which one or more of the
9 genotype-by-genotype combinations appeared in fewer than 20
individuals in our sample (Materials and Methods).
Testing for interaction between 7,750 pairs of SNPs for each of
four quantitative traits, we identified one significant interaction
underlying each of LDL-C level and HDL-C level (Figure 1a). The
interaction underlying LDL-C level is between rs2247056 and
rs1030431 (Bonferroni corrected Pc=0.003; Figure 1a). To
explore the interaction between the two loci with better resolution,
we tested for interaction between each SNP in the 100 kb
surrounding rs2247056 and each SNP in the 100 kb surrounding
rs1030431 and found that the interaction signal peaked between
rs2853928 and rs1993453 (Pc=0.01 after accounting for all
additional pairs of SNPs tested; Figure S1). The discovery SNP
pairs are in high LD with the fine-mapped SNP pairs, with an r
2
value of 0.997 between rs2247056 and rs2853928 and 0.999
between rs1030431 and rs1993453. The former two reside near a
pseudogene, LOC100133383, and the latter two are located near
and in gene UBXN2B, respectively. However, this suggestive
interaction underlying LDL-C did not replicate in independent
cohorts.
Henceforth, we focus on the interaction between rs12916 and
rs1532085 on HDL-C levels (Pc=0.008), since its validation in
additional cohorts is highly significant, as described below. We
first tested for interaction between each SNP in the 100 kb
surrounding rs12916 and each SNP in the 100 kb surrounding
rs1532085. While many of these pairs show significant interac-
tions (Figure 1b), as expected from LD, we observed the strongest
signal between rs3846662 and rs2043085 (Pc=0.002). The fine-
mapped pair of SNPs is in high LD with the original pair of
SNPs, with an r
2 value of 0.88 between rs3846662 and rs12916
and an r
2 value of 0.93 between rs2043085 and rs1532085
(Figure S2). rs3846662 is intronic in HMGCR (Table 1), which has
not been previously associated with HDL-C, but has been
associated with both TC and LDL-C levels [6]. rs2043085 is
upstream of LIPC (Table 1), which has been previously found to
be associated with HDL-C [6].
The interaction between rs3846662 and rs2043085 affects
HDL-C twice as much as the effect of the polymorphism in LIPC
alone: While individuals with TT genotype at rs2043085 already
exhibit an average increase of 2.63 mg/ml in HDL-C (standard
error (SE)=0.014; Figure 2a), this genotype in combination with
an AA genotype at rs3846662 leads to an average increase of
5.72 mg/ml (SE=0.041; Figure 2b). The linear model with these
two SNPs has an R-square value of 0.5% and the linear model
with the two SNPs and their interaction has an R-square value of
Author Summary
Genome-wide association studies (GWAS) have identified
many loci associated with complex human traits or
diseases. However, the fraction of heritable variation
explained by these loci is often relatively low. Gene–gene
interactions might play a significant role in complex traits
or diseases and are one of the many possible factors
contributing to the missing heritability. However, to date
only a few interactions have been found and validated in
GWAS due to the limited power caused by the need for
multiple-testing correction for the very large number of
tests conducted. Here, we used three types of prior
knowledge, known GWAS hits, protein–protein interac-
tions, and pathway information, to guide our search for
gene–gene interactions affecting four lipid levels. We
identified an interaction between HMGCR and a locus near
LIPC in their effect on high-density lipoprotein cholesterol
(HDL-C) and another pair of loci that interact in their effect
on low-density lipoprotein cholesterol (LDL-C). We validat-
ed the interaction on HDL-C in a number of independent
multiple-ethnic populations, while the interaction under-
lying LDL-C did not validate. The prior knowledge-driven
searching approach and a locus-based validation proce-
dure show the potential for dissecting and validating
gene–gene interactions in current and future GWAS.
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0.3% of the overall variation in HDL-C levels (Materials and
Methods; Table S1). We tested whether rs3846662 and rs2043085
exhibit gene-gene interactions underlying any of the other lipid
levels, and found a nominally significant interaction underlying
LDL-C (P=0.028), and almost significant interaction underlying
TG (P=0.08) in ARIC.
We performed a larger scale interaction analysis between all
pairs of SNPs that (i) are found in interacting genes according to a
curated human protein-protein interaction network (,6 million
Figure 1. QQ plots for gene–gene interaction tests. A) Discovery in ARIC EA cohort by testing all possible pairs of SNPs among the 125
previously associated SNPs [6], for each of the four traits, showing deviation from expectation for two of them, and pointing in each of these two
cases to a single pair of interacting SNPs (Table 1). B) Fine mapping in ARIC EA by testing all possible pairs of SNPs in the 100 kb surrounding rs12916
and rs1532085 that were found from panel A (HDL-C). C) Validation by testing SNP pairs surrounding rs3846662 and rs2043085 (found from panel B;
see also Table 1) in four additional cohorts, each pointing to significant gene-gene interaction between the two regions. For all, stage (iii) of the
adaptive locus-based validation procedure is shown, though replication has already been successful in stage (ii) in the MESA EA cohort.
doi:10.1371/journal.pgen.1002714.g001
Table 1. Significant interactions on HDL-C in multi-ethnic cohorts.
Test Stage Cohort
a SNP 1 SNP 2 Pc
d
chr pos
b rsID Gene
c chr pos
b rsID Gene
c
Discovery ARIC EA 5 74656539 rs12916 HMGCR (39 UTR) 15 58683366 rs1532085 40.8 k U LIPC 0.008
Fine Mapping ARIC EA 5 74651084 rs3846662 HMGCR (Intron) 15 58680954 rs2043085 43.2 k U LIPC 0.002
Validation MESA EA 5 74651084 rs3846662 HMGCR (Intron) 15 58582540 rs1973688 141.6 k U LIPC 0.006
Validation FHS EA 5 74651864 rs55727654 HMGCR (Intron) 15 58666341 rs473422 57.8 k U LIPC 0.002
Validation MESA HA 5 74602699 rs1423527 30.3 k U HMGCR 15 58718340 rs7163280 5.8 k U LIPC 0.04
Validation ARIC AA 5 74685520 rs3761743 27.6 k D HMGCR 15 58736623 rs567838 LIPC (Intron) 0.004
aEA denotes European American; HA denotes Hispanic American; AA denotes African American.
bBuild 37.1 (GRCh37).
cU indicates upstream of; D indicates downstream of.
dP-value after Bonferroni correction.
doi:10.1371/journal.pgen.1002714.t001
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and lipoproteins (,27 million pairs). All SNPs in a gene were
considered, as well as in the 5 kb regions upstream and
downstream. This analysis detected no significant gene-gene
interactions following Bonferroni correction (Pc$0.58 for PPIs;
Figure S3; Pc$0.14 for pathway; Figure S4).
Validation of gene–gene interaction in pairs of loci
Considering the quadratic reduction in replication power as a
function of LD between tag SNPs and causal loci, we aimed to
increase power via an adaptive locus-based validation procedure
that is related to that of Liu et al. [28]. In considering a replication
dataset, the procedure follows three sequential stages that leverage
the signals of proxy markers: (i) test for interaction between the
original SNP pair between which gene-gene interaction has been
detected; (ii) test for interactions between each of the two original
SNPs and each SNP in the proximate region containing the other
original SNP; (iii) test for interactions between each pair of SNPs
in each of the two respective proximate regions containing the two
original SNPs. This validation procedure proceeds sequentially
and stops at any stage when significant interactions were detected
after multiple-testing correction. Both the method of Liu et al. and
our adaptive locus-based validation method focus on replicating
the interaction between a pair of loci, rather than between a pair
of SNPs, due to the power limitations of replicating an interaction
between SNPs. The null hypothesis of the entire three-stage
procedure is that there is no interaction between the pair of loci,
rather than just between the pair of SNPs, thus the procedure
continues sequentially as described to consider proxy SNPs from
the loci containing each original SNP. Replication is successful if
an interaction between any SNP pair from the two loci is
significant after multiple-testing correction. Similar locus-based
approach has also been used in the context of gene-based GWAS
tests for single-marker association, which use an entire gene or
locus as the testing unit of association, rather than a single SNP
[27,32].
To validate the gene-gene interaction affecting HDL-C, we
performed replication analyses in two additional GWAS datasets
from the Framingham Heart Study (FHS) [33] and the Multi-
Ethnic Study of Atherosclerosis (MESA) [34], as well as in the
African American (AA) cohort from the ARIC study [29]. Using
our adaptive locus-based procedure, we tested for interaction
sequentially between SNPs surrounding rs3846662 and SNPs
surrounding rs2043085. We observed significant interactions in
the two additional EA cohorts from FHS and MESA (Figure 1c),
with Pc=0.002 and Pc=0.006 for the most significantly interact-
ing SNP pair (Table 1). Replication was also significant in
Hispanic Americans (HA) from MESA and AAs from ARIC
(Figure 1c; Table 1). The R-square of linear model with the two
interacting SNPs varies between 0.2–0.5% across the four
replication cohorts, with the interaction term between the two
explaining an additional 0.2–1.1% of the overall variation in
HDL-C levels (Table S1). The replication procedure failed in a
sample of AAs from MESA (Figure S5).
None of the successful replications were replicated at stage (i) of
the adaptive locus-based validation procedure, which means that
an interaction between the same SNP pair is not observed
significantly in the additional samples. The interaction was
successfully validated in stage (ii) of the three stages in the MESA
EAs, with the same SNP in HMGCR (rs3846662) and a proxy SNP
near LIPC exhibiting a significant gene-gene interaction after
multiple-testing correction. The other three successful replications
occurred at stage (iii) (Table 1), emphasizing the importance of a
locus-based replication approach. The combined evidence from
the discovery and four different validation cohorts for a gene-gene
interaction between the two loci under study is overwhelmingly
significant, even following a conservative Bonferroni correction
(Pc=9.0610
28).
While the gene-gene interaction signal peaks for different pairs
of SNPs across the different cohorts (Table 1), the type of
interaction and effect patterns appear consistent across several
sample sets (Figure S6). To test this formally, we partitioned the
Figure 2. Marginal and interaction effect sizes on HDL-C level in ARIC EA cohort. A) Boxplot of the effect sizes of rs2043085. Allele T of
rs2043085 leads to increased HDL-C, with median levels of 45.8, 46.9 and 49.3 mg/ml for CC, CT, and TT (difference in mean levels reported in main
text). B) Boxplot of the effect sizes of the SNP pair, rs3846662:rs2043085. The genotype AA:TT leads to a considerable increase of HDL-C. The median
HDL-C level in the entire sample is 46.7 mg/ml, while the median level for AA:TT is 52.7 mg/ml (rs2043085 is the only one of the two that is associated
by itself with HDL-C, hence shown in panel A).
doi:10.1371/journal.pgen.1002714.g002
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components on top of the marginal SNP effects, namely additive
by additive (A6A), additive by dominance (A6D), dominance by
additive (D6A), and dominance by dominance (D6D) compo-
nents (Materials and Methods). Considering a nominal signifi-
cance level of 0.01, D6A and D6D components are significant
and underlie the significant interaction in the ARIC EA discovery
set, between rs12916 and rs1532085 (Table S1). All four terms are
significant between the pair of SNPs, rs3846662 and rs2043085,
that resulted from fine mapping in the same discovery set, with
D6A and D6D being of the same effect direction (sign) and
similar effect sizes as between rs12916 and rs1532085 (Table S1).
Examining the two replication cohorts of a similar (EA) ancestry,
the interaction in the MESA cohort similarly shows significant
D6A and D6D components, with same effect direction, though
with larger effect sizes and a higher proportion of phenotypic
variance explained (Table S1). None of the four terms is significant
by itself in the EA FHS cohort. These results of consistent patterns
of interaction across the EA cohorts support the possibility that
they are all governed by the same (unobserved or partially
unobserved) interacting variants.
Validation of imputation accuracy
To verify that our results are not an artifact of imputation
errors, we compared imputed genotypes of the two SNPs (rs12916
and rs3846662) that were involved in significant interactions and
for which we could obtain measured genotype data from an
independent source, using the ITMAT/Broad/CARE (IBC)
Vascular Disease 50 k SNP Array chip [35]. For these two SNPs,
r
2 between imputed and actual genotypes is 0.914 and 0.921 and
the genotype concordance rate is 94.5% and 94.7%, respectively.
Although the imputation is not perfect, the two interaction tests
involving these two SNPs are at least as significant when replacing
imputed genotypes with measured IBC genotypes, consistent with
imputation errors adding noise and masking some of the signal,
rather than biasing the statistical test.
Discussion
Tests of gene-gene interactions are not as powerful as tests of
single-marker association, so a judicious strategy is essential for
successful interaction analysis in GWAS [9,36]. The first step is to
determine the size of the analysis, genome-wide or focusing on
candidate SNPs. This step should consider the sample size,
possible effect size of the underlying interaction, and the desired
statistical power. Current single-marker GWAS have been
successful in detection of single-marker associations for many
complex diseases or traits using a stringent genome-wide
significance level (P,5610
28). To achieve a similar success for
interaction analysis, we are limited to performing ,1 million tests
even if the interaction test and single-marker test had the same
statistical power. This limitation means that we are not able to
conduct an inclusive all-by-all pair-wise interaction analysis in
current GWAS. Thus, in this study we only tested for interactions
between candidate SNPs based on prior knowledge.
We used three types of prior knowledge, known GWAS hits,
protein-protein interaction networks, and known functional
pathways. These three analyses might be different in the
enrichment of epistasis signals and are also different in the
number of interaction tests, 7,750 based on known GWAS hits,
,6.2 million using PPI, and ,27 million with pathway
information. We found significant interactions from the 7,750
interaction tests using known GWAS hits. As the sample size of
,10,000 individuals is relatively large among existing GWAS, this
indicates that the observed (tagged) effect size of any other
underlying interactions is no larger than the marginal effects of
single SNPs. It is also likely that the epistasis signals are better
enriched between markers that are marginally associated with lipid
traits such that testing interactions among known GWAS hits is
more powerful in our study. Therefore, our results suggest that a
small-scale interaction analysis of candidate SNPs driven by
known marginal associations might be a good choice for detecting
epistatic interactions in current GWAS.
Recently, the Population Architecture using Genomics and
Epidemiology Study [37] found only ,50% of the 125 reported
associations with lipid levels [6] to replicate in three non-
European cohorts. Due to the quadratic decrease in the
interaction effect of tagged markers, gene-gene interactions are
even less likely to replicate in diverse populations. Leveraging
signals from proximate linked SNPs, our adaptive locus-based
method successfully validated gene-gene interactions between
HMGCR and LIPC in four additional, independent cohorts,
including two of non-European ancestry. Although the most
significant interaction in each cohort involves different SNPs,
they are proximate across the cohorts, with stronger LD and
smaller distances amongst the three EA cohorts and weaker LD
and larger distances between them and the HA and AA cohorts
(Figure S2 and Table 1). The differences in distance and LD
between ethnicities could be due to differences in genetic
background, demographic history, and natural selection, even if
the different SNP pairs capture the same underlying causal
interaction. However, the interaction shows similar patterns
among some, but not all cohorts (Figure S6 and Table S1), while
the different SNPs around HMGCR are in strong LD, and those
around LIPC show weak LD (Figure S2). These results suggest
that the five SNP pairs either capture separate causal interactions
or are only in weak LD with the same pair of interacting,
unobserved variants.
Another possibility is that the interaction is between relatively
rare causal variants: Much like rare causal variants can lead to
multiple independent associations of common variants, dubbed
‘‘synthetic associations’’ [38], an interaction between two rare
causal variants can produce an even larger number of independent
‘‘synthetic interactions’’, which can in principle explain almost-
independent, yet proximate gene-gene interactions. Another
possibility is that the underlying interaction is more complex and
involves more than a pair of SNPs. In that case, in our analysis of
pairs of SNPs, each pair might tag only certain aspects of the
underlying interaction.
Both HMGCR and LIPC are involved in metabolism of lipids
and lipoproteins. HMGCR, which has been associated with TC
and LDL-C [6], regulates the rate of cholesterol synthesis via a
negative feedback mechanism mediated by sterols and non-sterol
metabolites [39]. LIPC encodes hepatic lipase which is an
important enzyme in HDL metabolism [40] and has been
previously associated with HDL-C levels [6]. The interaction
between variants in these genes as discovered in this study can be
possibly explained by an indirect interaction between cholesterol
synthesis and the metabolism of LDL and HDL particles. HGMCR
is the rate-controlling enzyme in the mevalonate pathway for
cholesterol synthesis [41]. Much of this cholesterol will form
cholesteryl esters that will be packaged into various lipoproteins
including LDL, HDL, and TG-rich lipoproteins. There are a
number of known lipoprotein interactions that result in the flow of
cholesterol in the form of cholesteryl esters from LDL and VLDL
to HDL-C [42]. This cholesterol is later processed with the HDL
particle by either reabsorbing into the liver or excretion in the
urine [43].
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strongest signal has been observed in fine mapping in the discovery
panel, was recently associated with elevated HDL-C in an
additional cohort of individuals with mixed dyslipidemia [44].
Increased HDL-C may be related to modest inhibition of TG
hydrolysis in the HDL particle by hepatic lipase, slowing its
excretion in the urine along with its cholesterol content. Because
HMGCR has a major effect on cholesterol synthesis, it will also
indirectly affect the cholesterol content in the HDL particle
through its interaction with LDL and TG-rich particles. In
addition, LIPC has been reported to exhibit gene-gene interaction
with other genes associated with lipid traits [45,46], and HMGCR
has been reported to interact with ABCA1 in Alzheimer’s disease
risk [47]. While these results increase the plausibility of a biological
interaction between these two genes, we note that a statistical
gene-gene interaction does not necessarily entail an underlying
epistatic interaction in the biological sense [7]. We also note that
while we refer to the interaction as being between HMGCR and
LIPC, these two genes are implicated only by genomic proximity,
and we presented no direct evidence that these genes are the
interacting functional units.
We conclude that a focused study with higher enrichment of
putative signals might have improved power to detect gene-gene
interactions underlying complex diseases or traits. By focusing only
on SNPs that were previously associated with the studied trait,
HDL-C level, or any of a handful of related traits (other lipid
levels), we successfully identified an interaction between SNPs in or
near HMGCR and SNPs upstream of LIPC in European American
samples. By using a locus-wide validation procedure to overcome
the quadratic impact of partial SNP tagging on the observed
interaction effect size, we further replicated the interaction
between these loci in additional European American samples, as
well as in African American and Hispanic American samples.
Materials and Methods
Study descriptions
All work done in this paper was approved by local institutional
review boards or equivalent committees.
Atherosclerosis Risk in Communities (ARIC) Study. The
ARIC Study is a multi-center prospective investigation of
atherosclerotic disease [29]. EA and AA individuals aged 45–64
years at baseline were recruited from four communities: Forsyth
County, North Carolina; Jackson, Mississippi; suburban areas of
Minneapolis, Minnesota; and Washington County, Maryland. A
total of 15,792 individuals participated in the baseline examination
in 1987–1989, with three triennial follow-up examinations. We
conducted a discovery interaction analysis using 9,713 EAs from
this study, for whom phenotype and genotype data were available,
and considered 3,207 AAs from this study as one of the replication
cohorts.
Framingham Heart Study (FHS). The FHS is a three
generational prospective cohort [33]. 5,209 EAs were initially
recruited in 1948 in Framingham, Massachusetts to evaluate
cardiovascular disease risk factors. The second generation cohort
(5,124 offspring of the original cohort) was recruited between 1971
and 1975, and lipid measurements were obtained multiple times.
The third generation cohort (4,095 grandchildren of the original
cohort) was collected between 2002 and 2005, and one lipid
measurement was obtained. We considered as one of the
replication cohorts a sample of 6,575 individuals from FHS for
whom genotypes and lipid measurements were available, while
accounting for their relatedness (see Population stratification and
relatedness).
Multi-Ethnic Study of Atherosclerosis (MESA). MESA is
a prospective cohort study of 8,296 men and women aged 45–84
years recruited from 6 US communities (Baltimore, MD; Chicago,
IL; Forsyth County, NC; Los Angeles County, CA; northern
Manhattan, NY; and St. Paul, MN) [34]. MESA was designed to
determine the characteristics of subclinical cardiovascular disease
and its progression, hence adults were considered and individuals
with symptoms or history of medical or surgical treatment for
cardiovascular disease were excluded. Participants were enrolled
between July 2000 and August 2002 and self-reported their race/
ethnicity group as Caucasian or white, African American or black,
Spanish/Hispanic/Latino, or Chinese American. We attempted
replication in three cohorts from the first three of these ethnicities,
with 2,685, 2,588, and 2,174 individuals, respectively, for which
genotypes and lipid measurements were available. We discarded
777 Chinese Americans from our replication analysis because of
the small sample size.
Genotype data
We obtained Affymetrix 6.0 SNP array genotyping of samples
from the ARIC study [29]. We obtained Affymetrix 6.0 SNP array
genotyping of MESA samples and Affymetrix 500 K SNP array
genotyping of FHS samples from the database of Genotypes and
Phenotypes (dbGaP; MESA SHARe, downloaded in May 2011 and
Framingham Cohort, downloaded in April 2010) [48,49]. Genotype
quality control (QC) steps included the exclusion of individuals
with .10% missing data, and the exclusion of SNPs with call rates
,90%, minor allele frequencies (MAF)#1%, or Hardy-Weinberg
Equilibrium (HWE) test with P,10
26. For the pairwise interaction
test of each pair of SNPs we also required (i) sample size of each of
the nine possible genotype-by-genotype combinations of the two
SNPs being .20 in the discovery analysis and .10 in the
validation analysis; and (ii) LD of r
2,0.1 between the two SNPs
between which interaction is tested. The first requirement is a
generalization of the MAF requirement in single-marker analysis.
We used IMPUTE2 [50] with HapMap3 [51] and 1000
Genomes [52] reference haplotypes to impute untyped SNPs,
resulting in the same set of SNPs across cohorts. We did not
impute untyped SNPs in MESA HA samples since no appropriate
reference panel was available at the time we conducted our
analysis. We discarded imputed SNPs with information score less
than 0.6. Following this QC stage, we considered the genotype
with the maximum posterior probability, and discarded SNPs for
which this probability is ,0.8.
Lipid level measurements
We considered four lipid measurements: TC, LDL-C, TG, and
HDL-C. All measurements were done in the fasting state using
standard enzymatic methods. In all three studies, each lipid level is
measured at multiple time points and we considered the average
level per individual of each lipid in all our analyses. We applied a
log transformation to TG levels to normalize them in face of the
skewness in the original distribution, as previously proposed [6].
We excluded individuals known to be taking lipid-lowering
medications.
Gender, age, age squared, and body mass index (BMI) were
included as covariates in all analyses, similarly to GWAS based on
these phenotypes [6,26]. We averaged values for age and BMI
whenever multiple measurements were available, in line with the
averaging of lipid levels [6]. The average age was also squared and
included as a covariate. Plate is also included as a covariate in the
ARIC data since it is correlated with some of the lipid levels (‘‘plate
effect’’; data not shown).
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Principal component (PC) analysis was conducted using
EIGENSOFT [53]. Top 10 PCs were included in the analysis as
covariates to account for potential population stratification in each
of the ARIC and MESA cohorts. For FHS, we applied a mixed
model method to account for relatedness by performing the
interaction test on the residuals after removing familial structure
[26,54].
Gene–gene interaction test
As described in [30,31], we tested for interaction between two
SNPs on a quantitative trait as follows. Assume Y is the trait of
interest and Gi is the genotype of SNP i (i=1, 2). Gi denotes the
number of copies of the reference allele (0, 1, or 2). Two indicator
variables xi and zi are defined for each SNP as
xi~
1, Gi~0
0, Gi~1
{1, Gi~2
8
> <
> :
zi~
{0:5, Gi~0
0:5, Gi~1
{0:5, Gi~2
8
> <
> :
Two linear models were fitted. The first, model (1), allows for
additive and dominance effects at each SNP, but is strictly additive
(i.e. no interaction) over the two SNPs. The second, model (2),
allows for the four possible forms of genotype-by-genotype
interaction (additive6additive, additive6dominance, dominan-
ce6additive, and dominance6dominance) [55], as follows:
Y~Z0b0zx1a1zz1d1zx2a2zz2d2ze ð1Þ
Y~Z0b0zx1a1zz1d1zx2a2zz2d2z
x1x2iaazx1z2iadzz1x2idazz1z2iddze
ð2Þ
Here, b0 denotes a vector of intercept and covariates as described
above. ai and di denote the additive and dominance effects of SNP
i, and iaa, iad, ida, and idd are the four interaction effects between the
two SNPs.
We tested for the existence of an epistatic interaction of any type
by an F-test with four degrees of freedom between models (1) and
(2) [18]. The F-test with four degrees of freedom tends to be more
powerful when little is known about the underlying epistatic effect
in terms of the possible directions of the deviation from
independence of the additive effects. This test is similar to the
‘‘–epistasis’’ option in PLINK [56], except that only additive
effects and their interaction are considered in PLINK, and an F-
test with one degree of freedom is hence applied. We also
considered a test for ‘‘physiological epistasis’’ [7] under the same
model and obtained very similar results (data not shown).
Throughout the results, we report P values following a conserva-
tive Bonferroni correction. To compare the effects of the different
SNP pairs detected in our discovery and validation analyses, we
also estimated and tested the four interaction terms in model (2) for
each pair of SNPs from different cohorts using a t-test.
Prior knowledge driven searching strategy
Although we only focus on pairwise interaction analysis, the
total number of potential pairwise interaction tests across 2.5
million SNPs is still huge, about 3 trillion tests. Due to the huge
reduction in power entailed by multiple-testing correction for such
a large number of tests, it is crucial to restrict the number of tests a
priori. We aimed to enrich possible interaction signals in the
limited number of tests we considered through the following three
strategies.
GWAS hits. In total 95 loci were recently associated with TC,
HDL-C, LDL-C, or TG in a GWAS meta-analysis [6]. We
exhaustively tested the pairwise interactions among all the
significantly (P,5610
28) associated SNPs in these 95 loci, for a
total of 125 significant SNPs. For this approach, the total number
of interaction tests is 7,750 for each trait.
PPI. We assembled over 3000 high-confidence human PPIs
and for each exhaustively tested the pairwise interactions between
each SNP in the first gene and each SNP in the second gene. For
n1 and n2 being the numbers of SNPs in the first and second gene,
respectively, the number of interaction tests is n16n2 for this PPI.
Repeating this process for the 3000 PPIs, we tested a total of ,6.2
million SNP-SNP interactions. We obtained gene information
(hg18) from UCSC genome browser (http://genome.ucsc.edu/) to
map SNPs to genes, considering for each gene all SNPs from 5 kb
upstream to 5 kb downstream of the gene. These PPIs, however,
have no specific implications to lipid levels as they are not context-
based, and were collected under different physiological conditions.
Functional pathways. We tested for gene enrichment of the
96 genes reported in ref. 6 as associated with lipid levels. As
expected, the metabolism of lipids and lipoproteins pathway (www.
reactome.org) is the most significant pathway (P,10
220). There
are a total of 228 genes in this pathway, to which we mapped a
total of 12,716 SNPs similarly to above. We tested for pairwise
interactions between each pair of these 12,716 SNPs, yielding a
total of ,27 million tests.
Adaptive locus-based validation method
Liu et al. [28] developed a local validation strategy and validated
a few interactions affecting common human diseases. This strategy
attempts to replicate the interaction between two loci rather than
the interaction between the original pair of SNPs. To further
improve power, we extended this local validation strategy to an
adaptive locus-based validation procedure: For a detected
interaction between SNP A and SNP B in the discovery panel
we followed three stages in each of the validation panels. (i) First,
test for interaction between SNP A and SNP B; (ii) Second, if the
interaction in (i) is not significant by itself, test for interaction
between A and each SNP,200 kb away from B, and similarly
between B and each SNP surrounding A; (iii) Last, if no test in the
second stage is significant following multiple-hypothesis correction,
test for interaction between each SNP,100 kb away from A and
each SNP,100 kb away from B. Assuming n1 and n2 SNPs in the
locus surrounding A and B, respectively, the number of interaction
tests performed is 1, n1+n2, and n16n2 in the three stages,
respectively, with n1 and n2 in stage (iii) being smaller than those in
stage (ii) due to considering only 100 kb. To maintain power in
light of multiple-testing correction, the validation process proceeds
sequentially and stops once we find significant results after
multiple-testing correction. The interaction between rs3846662
and rs2043085 on HDL-C was successfully validated in stage (ii)
for MESA EA samples and in stage (iii) for the MESA HA, FHS
EA, ARIC AA cohorts. It did not validate significantly after
multiple-testing correction in any of the three stages in the MESA
AA samples. We used the same procedure as in step (iii) for fine
mapping within the discovery panel.
Supporting Information
Figure S1 Quantile–quantile (QQ) plots for gene–gene interac-
tion tests of LDL-C in ARIC EA cohort. (A) Discovery analysis
(reproduced from Figure 1a in main text); (B) Fine mapping by
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rs2853928 and rs1993453.
(TIF)
Figure S2 Linkage disequilibrium in data from the 1000
Genomes Project of all SNPs involving in significant interactions
underlying HDL-C in any of the cohorts (i.e. all SNPs from
Table 1). (A) and (C) are for SNPs in the locus on chromosome 5 in
the CEU (European American) and YRI (West African) 1000
Genomes samples, respectively; similarly, (B) and (D) for SNPs on
the interacting locus on chromosome 15. These figures were
produced by Haploview [57]. The numbers shown are R-square
values with zeroes and dots omitted.
(TIF)
Figure S3 QQ plots for gene–gene interaction tests in ARIC EA
cohort based on the PPI-based strategy for considering pairs of
SNPs. (A) TC; (B) LDL-C; (C) TG; (D) HDL-C.
(TIF)
Figure S4 QQ plots for gene–gene interaction tests in ARIC EA
cohort based on the pathway-based strategy for considering pairs
of SNPs. (A) TC; (B) LDL-C; (C) TG; (D) HDL-C. We found a
deviation in the QQ plot of the P values for interactions
underlying TC levels and the strongest interaction signal appears
between rs4804546 and rs914196, though it is not significant
following correction for the ,27 million tests (Pc=0.14). The two
genes from the pathway of metabolism of lipids and lipoproteins
associated with this interaction are CARM1 and AGPAT3. AGPAT3
was previously found to be associated with the level of
phospholipid [58], while CARM1 has not been associated to the
best of our knowledge with any lipid levels.
(TIF)
Figure S5 QQ plots for stage (iii) of the adaptive locus-based
validation tests in MESA African American cohort, which show no
significant results.
(TIF)
Figure S6 Effect sizes on HDL-C level of the six SNP pairs from
Table 1 in main text in the respective cohorts. The ARIC EA fine
mapping panel is reproduced from Figure 2B in main text.
(TIF)
Table S1 Effect estimates for significant interactions between
SNPs surrounding HMGCR and LIPC on HDL-C in EA, AA, and
HA cohorts.
(DOC)
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